FT. LAUDERDALE, Fla., March 14, 2008 (PRIME NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer of MAKO Surgical Corp., is scheduled to present an overview of the company at the 28th Annual Cowen and Company Healthcare Conference in Boston, MA on Tuesday, March 18, 2008, at 3:10 p.m.
The presentation will be webcast live and may be accessed by visiting MAKO's website at www.makosurgical.com. A replay of the webcast will be available immediately after the conclusion of the presentation. Investors can access the webcast under the Investor Relations section of the MAKO website.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets its advanced robotic arm solution and implants for minimally invasive orthopedic knee procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) includes a surgeon-interactive tactile robotic arm platform that utilizes a robotic arm and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a minimal incision. This FDA-cleared TGS(tm) allows surgeons to provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics and implants.